Featuring an interview with Dr Christopher L Moertel, including the following topics:

• Overview of neurofibromatosis type 1(NF1) (0:00)
• Cancer in NF1 (8:38)
• Dermatologic manifestations of NF1 (16:57)
• Treatment options for NF1 (20:43)
• Malignant peripheral nerve sheath tumors (MPNST) (25:14)
• FDA-approved MEK inhibitors for NF1 plexiform neurofibromas (28:36)
• Specializing in NF (44:44)

CME information and select publications